BPT Crunch

Companies on the Cutting Edge of Healthcare Innovations

back to Marketplace

AbCellera

AbCellera logo

Founded
2012
Geography
Canada based
Funding
$851.718 M

AbCellera is a privately held technology company with an antibody discovery platform that searches and analyzes natural immune systems to find antibodies that can be used to prevent and treat disease. AbCellera’s technology, which combines high-throughput microfluidics, hyper-scale data science, machine learning, bioinformatics, and genomics, identifies new drug candidates and aims to reduce the time it takes to bring treatments to the clinic. AbCellera's partners include leading biotechnology companies, global health organizations, and many of the top 10 biopharmaceutical companies.

Technologies

AI Companies (Drug Discovery)  


Posts Mentioning This Company

Biopharma Insights

R&D Platform

Explore large multidimensional data with Celium™, our proprietary antibody visualization software.


Celium™
antibody

Read more

Pipelines

No pipelines published yet

Products

 

Services

No services posted yet